David W Kuo

Title: David W Kuo: Innovator in Metabolic Pathway Assays

Introduction

David W Kuo is a notable inventor based in Princeton, NJ (US). He has made significant contributions to the field of biochemistry, particularly in the development of innovative assays for enzyme inhibitors. His work is instrumental in advancing the understanding of metabolic pathways and their applications in drug discovery.

Latest Patents

David W Kuo holds a patent for a "Metabolic pathway assay." This invention is an in vitro screening assay that identifies enzyme inhibitors while allowing for the simultaneous assay of multiple enzymes. The assay optimizes concentrations of enzymes, substrates, co-factors, and other components to ensure that inhibitors of any one enzyme in the pathway are equally likely to be detected. The design of the assay ensures that the flux of substrate through each enzyme remains nearly constant, making each enzyme-catalyzed step equally rate-limiting. Additionally, optimal assay conditions are predicted through computer modeling, enhancing the efficiency of the process.

Career Highlights

David W Kuo is associated with Merck & Co., Inc., where he applies his expertise in biochemistry and enzymology. His work at Merck has contributed to the development of new therapeutic strategies and has had a lasting impact on the pharmaceutical industry.

Collaborations

Throughout his career, David has collaborated with esteemed colleagues, including Renee M Chabin and John F O'Connell. These collaborations have fostered a productive environment for innovation and research.

Conclusion

David W Kuo's contributions to the field of metabolic pathway assays exemplify the importance of innovation in biochemistry. His patent and work at Merck & Co., Inc. highlight his role as a key figure in advancing enzyme research and drug discovery.